ARK Genomic Revolution ETF Sees Unusually High Options Volume (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the recipient of unusually large options trading activity on Friday. Traders acquired 7,236 call options on the company. This is an increase of 52% compared to the typical daily volume of 4,746 call options.

ARK Genomic Revolution ETF Stock Performance

BATS:ARKG opened at $26.04 on Friday. The company has a 50 day moving average price of $27.58 and a two-hundred day moving average price of $31.12.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of ARKG. Wells Fargo & Company MN grew its position in ARK Genomic Revolution ETF by 11.2% during the second quarter. Wells Fargo & Company MN now owns 2,752,614 shares of the company’s stock valued at $93,837,000 after buying an additional 277,885 shares during the period. Citigroup Inc. boosted its position in ARK Genomic Revolution ETF by 1.2% during the second quarter. Citigroup Inc. now owns 1,419,004 shares of the company’s stock worth $48,374,000 after purchasing an additional 16,147 shares during the period. Main Management ETF Advisors LLC boosted its position in ARK Genomic Revolution ETF by 25.2% during the first quarter. Main Management ETF Advisors LLC now owns 247,250 shares of the company’s stock worth $7,435,000 after purchasing an additional 49,710 shares during the period. Cambridge Investment Research Advisors Inc. boosted its position in ARK Genomic Revolution ETF by 6.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 217,825 shares of the company’s stock worth $6,550,000 after purchasing an additional 12,532 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its position in ARK Genomic Revolution ETF by 98,051.8% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 215,934 shares of the company’s stock worth $7,361,000 after purchasing an additional 215,714 shares during the period.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.